Relationship between intracoronary thrombus burden and systemic immune-inflammation index in patients with ST-segment

Abdullah Kadir Dolu1, Orhan Karayiğit2, Can Ozkan3

  • 1Department of Cardiology, Izmir Katip Çelebi University Ataturk Education and Research Hospital, Izmir, Turkey.

Acta Cardiologica
|February 2, 2022
PubMed

Insights

The systemic immune-inflammation index (SII) effectively predicts high thrombus burden in ST-elevation myocardial infarction (STEMI) patients. SII demonstrates superior predictive capability compared to neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR).

Area of Science:

  • Cardiology
  • Immunology
  • Biomarkers

Background:

  • Intracoronary thrombus burden is a critical factor in ST-elevation myocardial infarction (STEMI).
  • Inflammatory markers, including neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), have been investigated as predictors in cardiovascular diseases.
  • The systemic immune-inflammation index (SII) is a composite marker reflecting systemic inflammation and immune cell status.

Purpose of the Study:

  • To evaluate the relationship between intracoronary thrombus burden and SII in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).
  • To compare the predictive capacity of SII against NLR and PLR for high thrombus burden in this patient cohort.

Main Methods:

  • A total of 425 STEMI patients who underwent PPCI were analyzed.
  • Intracoronary thrombus burden was assessed using the Thrombolysis in Myocardial Infarction (TIMI) thrombus classification.
  • SII was calculated as platelet count × neutrophil count / lymphocyte count. NLR and PLR were also computed.

Main Results:

  • High NLR, PLR, SII, and low left ventricle ejection fraction (LVEF) were identified as independent predictors of high thrombus burden.
  • SII values above 812 demonstrated significant predictive power for high thrombus burden (AUC: 0.836).
  • The predictive performance of SII was superior to that of NLR (AUC: 0.818) and PLR (AUC: 0.780).

Conclusions:

  • The systemic immune-inflammation index (SII) is an independent predictor of high thrombus burden in STEMI patients.
  • SII exhibits superior predictive capacity for high thrombus burden compared to NLR and PLR in this population.
  • These findings suggest SII could be a valuable biomarker for risk stratification in STEMI patients.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
52
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
38
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
105
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
73
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
69